fbpx

How the Delta Variant Fight Will Unleash a Wave of Genomics Innovation

Here we go again… Just when we thought the pandemic was over and it would be just a matter of time before life returned to normal, the delta variant comes along. We’re now in the middle of a third wave of COVID-19. With the seven-day average of reported infections running at more than 100,000 as … Read More

The #1 DNA Stock Leading the Genomic Revolution?

Precision medicine just took a HUGE step forward… CRISPR gene-editing technology was used on humans for the first time. Biotech company Intellia Therapeutics Inc. (Nasdaq: NTLA) achieved the milestone in a clinical trial in June. CRISPR editing was used to treat people with a rare protein disorder. Not only was the treatment safe, but preliminary … Read More